Clinical Trial Update: Study Evaluating the Effects of DVS SR and Duloxetine on the Pharmacokinetics of Desipramine in Healthy Subjects [Phase 3]

View source ↗

Summary

A Phase 3 trial completed to evaluate whether DVS SR and duloxetine affect the pharmacokinetics of desipramine in healthy subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• DVS SR
• Desipramine (desipramine)
• Duloxetine (DULOXETINE)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Depression, Depressive Disorder | Phase 3 | Status: COMPLETED